The impact of body mass index on rectal dose in locally advanced cervical cancer treated with high-dose-rate brachytherapy

Obesity decreases the rectal dose given in high-dose-rate brachytherapy for locally advanced cervical cancer because of an increase in fatty tissue in the recto-uterine space. There is no significant correlation between BMI and acute or late GI toxicity.